News & Analysis

Charterhouse closes Goldman-anchored pharma continuation fund deal

The process is understood to have also involved Charterhouse's latest fund in market acquiring a portion of pharmaceutical group SERB.

8 June 2023•2 mins read

Deals Western Europe Single Assets Featured GP-Leds

Related articles

alt

Swiss LP adviser InPact enters infra secondaries, eyes PE GP-leds

26 August 2026 · 3 mins read

alt

QIC targets shorter plays amid PE’s liquidity crunch

26 August 2026 · 3 mins read

alt

CIP bolsters its liquidity capabilities, hiring head of capital solutions

25 August 2026 · 2 mins read

alt

Secondaries’ emerging leaders: GP-leds to become a proactive portfolio management tool

24 August 2026 · 2 mins read

alt

CV pricing strengthens amid growing buyer competition

21 August 2026 · 3 mins read

alt

Korean LPs embrace PE secondaries, mid-market amid credit controversy

20 August 2026 · 5 mins read

alt

Behind the $400m CFO formed by Churchill and Temasek’s Seviora

20 August 2026 · 5 mins read

motif